Difference between revisions of "COVID-19 and emerging viral infections: The case for interferon lambda (DOI: 10.1084/jem.20200653) (Q10304)"
Jump to navigation
Jump to search
(Added reference to claim: Author (P97): Durbin JE (4th author of DOI: 10.1084/jem.20200653) (Q10308), #quickstatements; #temporary_batch_1592857754139) |
(Created claim: Author (P97): Glenn JS (5th author of DOI: 10.1084/jem.20200653) (Q10309), #quickstatements; #temporary_batch_1592857754139) |
||
| Property / Author | |||
| + | |||
| Property / Author: Glenn JS (5th author of DOI: 10.1084/jem.20200653) / rank | |||
| + | Normal rank | ||
Revision as of 20:29, 22 June 2020
Research article published in J. Exp. Med.; 2020 05 04 ; 217 (5)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
COVID-19 and emerging viral infections: The case for interferon lambda (DOI: 10.1084/jem.20200653)
|
Research article published in J. Exp. Med.; 2020 05 04 ; 217 (5)
|
Statements
J. Exp. Med.; 2020 05 04 ; 217 (5).
COVID-19 and emerging viral infections: The case for interferon lambda (English)
